Ashwani Kumar

Ashwani Kumar

Auto-generated profile, based on publicly available information

Ashwani Kumar

Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science & Technology, Hisar, India

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

22 June 2020 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
LDLaxmi Deswal
Laxmi Deswal
VVVikas Verma
Vikas Verma
DKDevinder Kumar
Devinder Kumar
CKChander P. Kaushik
Chander P. Kaushik
AKAshwani Kumar
Ashwani Kumar
SPSuman Punia
Suman Punia

1 August 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AKAshwani Kumar
Ashwani Kumar
SCShilpi Chauhan
Shilpi Chauhan

19 February 2019 in SAR and QSAR in Environmental Research
Verified
Journal Article
Closed access
MAManisha
Manisha
SCS. Chauhan
S. Chauhan
PKP. Kumar
P. Kumar
AKA. Kumar
A. Kumar
Fructose-1,6-bisphosphatase (FBPase) is an enzyme important for regulation of gluconeogenesis, which is a major process in the liver responsible for glucose production. Inhibition of FBPase enzyme causing blockage of the gluconeogenesis process represents a newer scheme in the progress of anti-diabetic drugs. The current research describes the development of hybrid optimal descriptors-based quantitative structure–activity relationship (QSAR) models intended for a set of 62 FBPase inhibitors with the Monte Carlo method. The molecular structures were expressed by the simplified molecular input line entry system (SMILES) notation. Three splits were prepared by random division of the molecules into training set, calibration set and validation set. Statistical parameters obtained from QSAR modelling were good for various designed splits. The best QSAR model showed the following parameters: the values of r2 for calibration set and validation set of the best model were 0.6837 and 0.8623 and of Q2 were 0.6114 and 0.8036, respectively. Based on the results obtained for correlation weights, different structural attributes were described as promoter of the endpoint. Further, these structural attributes were used in designing of new FBPase inhibitors and a molecular docking study was completed for the determination of interactions of the designed molecules with the enzyme.


11 December 2019 in Structural Chemistry
Verified
Journal Article
Closed access
PDF file
MNManisha Nimbhal
Manisha Nimbhal
KBKiran Bagri
Kiran Bagri
PKParvin Kumar
Parvin Kumar
AKAshwani Kumar
Ashwani Kumar